In addition, hepatic silencing of lncARSR in NAFLD mice via tail vein injection of lentivirus-sh-lncARSR markedly reduced lipid accumulation and triacylglycerol content in the livers. The gene discussed is LNCARSR; the disease is metabolic dysfunction-associated steatotic liver disease.